Alder BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial and Operating Results Pharmaceutical Investing
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017 Pharmaceutical Investing
Positive Regulatory News from Two Pharmaceutical Companies Triggers Share Price Increases Pharmaceutical Investing
KemPharm Announces FDA Approval of Apadaz for the Short-Term Management of Acute Pain Pharmaceutical Investing
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Massachusetts Medical School Pharmaceutical Investing
Summit Announces New Analysis Showing Ezutromid Significantly Reduced Muscle Inflammation in Phase 2 Clinical Trial in DMD Biotech Investing
Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial Genetics Investing
Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results Genetics Investing
Neos Therapeutics Launches Adzenys ER (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD Pharmaceutical Investing
ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
